Drug

Faricimab

Evidence, trials and EU product information for faricimab.

Connected reading

Trial updateOphthalmology

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

ClinicalTrials.gov · 18 Sept 2026

Regulatory updateRetina

Faricimab: start with the current EU product information

European Medicines Agency · 17 Sept 2026

Trial updateRetina

Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting

ClinicalTrials.gov · 16 Sept 2026

References